Swedencare AB (publ) Logo

Swedencare AB (publ)

Develops and markets premium health supplements and pharmaceuticals for cats, dogs, and horses.

SECARE | ST

Overview

Corporate Details

ISIN(s):
SE0015988167
LEI:
549300FZT7YIF6SWX789
Country:
Sweden
Address:
C/O Medeon Science Park, 205 12 Malmö
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Swedencare AB is a global group that develops, produces, and markets premium pet health products, primarily for cats, dogs, and horses. The company's portfolio includes a range of strong brands offering supplements, natural and organic products, and specialty pharmaceuticals. A key component of its growth strategy is the acquisition of established companies to expand its market presence and product offerings. Swedencare utilizes a multi-channel distribution model, selling its products through a global network of veterinary clinics, pet stores, and leading e-commerce platforms like Amazon and Chewy. The company focuses on innovation and aims to outperform market growth by meeting the increasing consumer demand for high-quality pet care.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Swedencare AB (publ) filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Swedencare AB (publ)

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Swedencare AB (publ) via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-04-24 Thomas Eklund Other Buy 12,560 426,412.00 SEK
2025-01-08 Laszlo Janos Varga Other Buy 500 22,550.00 SEK
2025-01-07 Laszlo Janos Varga Other Buy 500 23,420.00 SEK

Peer Companies

CKD Bio Corp. Logo
Develops and manufactures probiotics & APIs using fermentation, also offering cGMP CMO services.
South Korea
063160
Clearmind Medicine Inc. Logo
Develops psychedelic-derived medicines for Alcohol Use Disorder and mental health conditions.
United States of America
CMND
Clearside Biomedical, Inc. Logo
Developing therapies for back-of-the-eye diseases via proprietary suprachoroidal delivery.
United States of America
CLSD
Clene Inc. Logo
Developing nanocrystal therapies for neurodegenerative diseases like ALS and MS.
United States of America
CLNN
CMG Pharmaceutical Co., Ltd. Logo
Develops and manufactures prescription drugs, specializing in Oral Thin Film (OTF) technology.
South Korea
058820
CNS Pharmaceuticals, Inc. Logo
Biotech developing drugs that cross the blood-brain barrier for brain and CNS cancers.
United States of America
CNSP
Cocrystal Pharma, Inc. Logo
Develops novel antiviral drugs for influenza, coronaviruses, norovirus, and hepatitis C.
United States of America
COCP
Co-Diagnostics, Inc. Logo
Develops patented PCR solutions for accurate infectious disease diagnostics.
United States of America
CODX
co.don AG Logo
Develops personalized cartilage cell transplants for minimally invasive joint repair.
Germany
CNW
Coeptis Therapeutics Holdings, Inc. Logo
Develops cell therapy platforms for cancer, autoimmune, and infectious diseases.
United States of America
COEP

Talk to a Data Expert

Have a question? We'll get back to you promptly.